Biotech Showcase™ 2017: J&J poised to establish no-strings-attached JLABS outside America

January 19, 2017

As Johnson & Johnson announced the establishment of its eighth JLABS facility, in collaboration with New York State and the New York Genome Center, Melinda Richter, head of Johnson & Johnson Innovation, JLABS, tells Mike Ward, global director of content at Informa Pharma Intelligence’s insights portfolio, that the company is actively looking to establish JLABS in Europe and Asia with an expectation that there will be news on this front in the near future.

 


Meet Johnson & Johnson at BIO-Europe Spring® springtime partnering conference taking place in Barcelona, Spain March 20–22, 2017. Find out more.

 

Previous Video
Biotech Showcase™ 2017: Janssen focuses cardiometabolic R&D on prevention, cure and interception
Biotech Showcase™ 2017: Janssen focuses cardiometabolic R&D on prevention, cure and interception

With readouts in important trials of key drugs Invokana and Xarelto on the horizon, Dr. James F. List, Glob...

Next Video
Biotech Showcase™ 2017: Reinventing Arena to focus on Phase II clinical candidates
Biotech Showcase™ 2017: Reinventing Arena to focus on Phase II clinical candidates

In the six months after joining Arena Pharmaceuticals as CEO, Dr. Amit Munshi has been busy: reducing the c...